JESSICA PEREZ: Open Payments
NPI 1487312211 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 70 payments from 16 companies in 2025. Trend: 2023 $1,208 · 2024 $877 · 2025 $1,422
Food & beverage: $1,422
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $419 |
| ABBVIE INC. | 19 | $240 |
| Lundbeck LLC | 5 | $115 |
| Neurocrine BioSciences, Inc. | 4 | $108 |
| Axsome Therapeutics, Inc. | 5 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $78 |
| Corium, LLC | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $69 |
| Alkermes, Inc. | 3 | $66 |
| Otsuka America Pharmaceutical, Inc. | 1 | $33 |
Products named: COBENFY, VRAYLAR, INGREZZA, REXULTI, Auvelity, Qelbree, Azstarys, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
